EPISODE · Sep 11, 2021 · 45 MIN
TWiV 803: COVID-19 clinical update #79 with Dr. Daniel Griffin
from This Week in Virology · host Vincent Racaniello
In COVID-19 clinical update #79, Daniel Griffin discusses clinical management guidelines, ER visits and hospitalization among children, infection and vaccine induced seroprevalence in the US, antibodies in Kenyan blood donors, infections after vaccination, anticoagulation for thromboprophylaxis, baracitinib efficacy, long-term symptoms in adults, and sustained symptoms after severe disease. Hosts: Daniel Griffin and Vincent Racaniello Subscribe (free): iTunes, Google Podcasts, RSS, email Become a patron of TWiV! Links for this episode Overlooked shortcomings of observational studies (Op For Inf Dis) Guidelines for clinical management (Op For Inf Dis) ER visits and hospitalization among children (MMWR) Hospitalization of adolescents (MMWR) Seroprevalence in the US (JAMA) Seroprevalence in Kenya (JAMA) Infections after vaccine (medRxiv) Israel data dashboard Guidelines on anticoagulation for thromboprophylaxis (Blood Adv) Baricitinib efficacy (Lancet) Long term symptoms, US adults (MMWR) Severe disease associated with long term symptoms (medRxiv) Letters read on TWiV 803 Timestamps by Jolene. Thanks! Intro music is by Ronald Jenkees Send your questions for Dr. Griffin to [email protected]
NOW PLAYING
TWiV 803: COVID-19 clinical update #79 with Dr. Daniel Griffin
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m